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Outlined below are the scheduled State-of-the-Art Lectures and
Symposia for each of the seven themes on the Congress plus
surrounding presentations on additional topics not covered in
the content of the themes. These invited presentations will be
complemented by multiple Free Communication sessions (oral
and poster).
The deadline for the receipt of abstracts is December 15, 1992.
For information write to the Secretariat, XIIth International
Congress of Nephrology, P. 0. Box 50006, Tel Aviv 61500,
Israel (Tel.: 972-3-5174571; Fax: 972-3-660325).
THEME 1. BIOLOGY OF GLOMERULAR INJURY
Co-Organizers: H. L. Moses, USA
R. C. Atkins, Australia
STA TE-OF-THE-ART LECTURES
Integrins (E.I. Rouslahti, USA); Cytokines/Growth Factors
(H.L. Moses, USA); Endothelial-Leukocyte Interactions (R.
Cotran, USA); Vasoactive and Proinflammatory Mediators of
Glomerular Injury (G. Remuzzi, Italy); Pathogenesis and
Clinical Spectrum of Focal Glomerular Sclerosis (H.G.
Rennke, USA).
SYMPOSIA
1. Glomerular Cells as Targets and Reactants in Injury
(Chair: R. Ardaillou, France)
Mesangial Cells (B. Sterzel, Ger.); Epithelial Cells (D.
Kerjaschki, Austria); Endothelial Cells (P. Marsden,
Can.); Transgenic Models (L. Striker, USA).
2. Matrix Production and Degradation (Chair: E.I. Rous-
lahti, USA)
Structure and Function of Matrix Macromolecules (G.
Timpi, Ger.); Structure, Function and Regulation of
Basement Membrane Proteoglycans (J. Hassell); Type
IV Collagen: Regulation of Expression (P.D. Killen,
USA); Proteinases and Matrix Turnover (M. Davies,
UK).
3. Mechanisms of Cytokine Action (Chair: H.L. Moses,
USA)
Receptors: IL-2 (W. Leonard, USA); Cytokine Recep-
tor Inhibition (IL-lAb) IL-i (J.-M. Dayer, Switz.);
Cytokines and Signalling (J. Schlesinger, USA); Intra-
cellular Inhibitors of Cytokine Action on Cell Prolifer-
ation (A. Balmain, UK).
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4. Cytokines and Glomerular Inflammation (Chair: L.
Baud, France)
TNF (L. Baud, France); TGF0 (W. Border, USA);
PDGF (H. Abboud, USA); IL-6 and IL-8 (Matsushima,
Japan).
5. Adhesion Molecules in Inflammation (Chair: R.C. At-
kins, Aust.)
Participants: H. Brady, USA; R.C. Atkins, Aust.; D.
Haskard, UK.
6. Mediators of Inflammation (Chair: W. Couser, USA)
Complement and Complement Inhibitors (W. Couser,
USA); Arachidonate Metabolites (J. Bernheim, Israel);
Coagulation (E. Rondeau, France); Oxygen Radicals
(Inoue, Japan).
7. Advances in Vasculitis and Rapidly Progressive Glomer-
ulonephritis (Chair: R. Wiggins, USA)
Mechanisms of Crescent Formation (R. Wiggins,
USA); Anti-endothelial Antibodies in Vasculitis (C.
Savage, UK); ANCA (R. Falk, USA); Clinical and
Pathophysiological Aspects of Vasculitis and Pauci-
Immune Glomerulitis (C.M. Kallenberg, Neth).
8. Mechanisms of Progression of Glomerular Disease
(Chair: H.G. Rennke, USA)
Lipids and Macrophages: Mechanisms of Protection
(G. Schreiner, USA); Ammonia, Complement and Tu-
bulointerstitial Damage (K. Nath, USA); Altered Per-
meability to Proteins (T. Bertani, Italy); Hemodynamic
Mechanisms (J. Herrera-Acosta, Mex).
THEME 2. BIOLOGY OF THE TUBULE EPITHELIAL
CELL
Organizer: H. Murer, Switz.
STATE-OF-THE-ART LECTURES
Kidney Cells in Culture: A Way to Understand Tubule
Function at a Molecular Level (H. Murer, Switz.); Na-K-
ATPase: Structure, Function and Gene Regulation (I. Lin-
grel, USA); The Structure and Function of Water Channels
(W. Harris, USA); Structure-Function Studies of the Cystic
Fibrosis Gene Product (R.A. Frizzel, USA); Molecular Biol-
ogy of Na/H-Exchanger Isoforms (J. Pouyssegur, France).
SYMPOSIA
1. Tubule Cells in Culture (Chair: M. Cereijido, Mex.)
The Making of a Transporting Epithelium Depends on
Extraceliular Signals (M. Cereijido, Mex.); All Re-
sponse of Proximal Tubule Cells in Primary Culture of
Derived Cell Lines (U. Hopfer, USA); Expression of
Specific Functions in Immortalized Tubule Cells (P.
Ronco, France); Cell Culture in the Study of Polycystic
Kidney Disease (J.J. Grantham, USA).
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2. Tubule Cells in Culture: Models of Polarity (Chair: W.J.
Nelson, USA)
Cell Adhesion and the Development of Epithelial Cell
Polarity (W.J. Nelson, USA); Role of Actin Binding
Proteins in the Development of Brush Border (D.
Louvard, France); Biogenesis of Epithelial Cell Polar-
ity (E. Rodriquez-Boulan, USA); Polarized Delivery of
Membrane Transporters in Renal Tubule Epithelial
Cells (D. Brown, USA).
3. Na-K-ATPase (Chair: D. Fambrough, USA)
Altered States: Mutant Hybrid and Chimeric Pumps
(D. Fambrough, USA); Functional Heterogeneity of
Na-K-ATPase in the Nephron and Its Pathophysiolog-
ical Regulation (A. Doucet, France); Hormonal Regu-
lation of the Na-K-ATPase in Kidney Cells (B. Ross-
ier, Switz.); Pathophysiologic Perspectives of Na-K-
ATPase (H. Wald, Israel).
4. H-ATPase (Chair: S. Gluck, USA)
Structure and Functure and Function of the Vacuolar
H-ATPase in Renal Epithelial Cells (S. Gluck, USA);
Expression of H-K-ATPase-Like Proteins in the Kid-
ney and in Transfected Epithelial Cells in Culture (M.
Caplan, USA); Physiological Perspectives of ATP-
Driven H-Extrusion Mechanisms in the Nephron (E.
Bello-Reuss, USA).
5. Sodium Channels/Potassium Channels (Chair: G. Giebi-
sch, USA)
Regulation of K and Cl Channel in Epithelia (R.
Greger, Ger.); Molecular Biology of Renal K Chan-
nels (W. Guggino, USA); Molecular Properties of
Epithelial Sodium and Potassium Channels (M. Laz-
dunski, France); Physiological Perspectives of Defined
K-Channels in the Nephron (G. Giebisch, USA).
6. Chloride Channels (Chair: Q. Al-Awqati, USA)
The Chloride Channel of Intracellular Organelles and
Its Physiological Regulation (Q. Al-Awqati, USA);
Regulation of Expression of Cl Transport in Epithelial
Cells (Z.I. Cabantchick, Israel); Structure and Func-
tion of Voltage-Gated Chloride Channels (T. Jentsch,
Ger.); Structure Function Studies of Epithelial Chlo-
ride Channel (J.W. Hanrahan, Can.).
7. Na-Dependent Co-transport (Chair: J. Handler, USA)
Cloning, Structure and Regulation of Renal Osmolyte
Transporters (J. Handler, USA); Structure and Regu-
lations of the NaIKI2C1 Co-transport System (E. Hoff-
man, Den.); Molecular Aspects of Renal NaJPi-Co-
transport (J. Biber, Switz.); Modulation of Na/Solute
Co-Transporters by Mediators and Lipidic Environ-
ment: Physiological Implications (G. Friedlander,
France).
8. Anion Exchangers (Chair: S.L. Alper, USA)
Anion Exchanger Expression and Regulation in Other
Epithelial Cells (S.L. Alper, USA); Anion Exchanger
and Stilbene-Sensitive Anion Transporters in the Prox-
imal Tubule (P.S. Aronson, USA); Structure and Func-
tion of Cation-Independent Anion Exchangers (R.R.
Kopito, USA); Anion Exchangers in Rabbit heal En-
terocytes (R.G. Knickelbein, USA).
THEME 3. REGULATION OF THE IMMUNE RESPONSE
Co-Organizers: I. Cohen, Israel
T. Strom, USA
STA TE-OF-THE-ART LECTURES
T Cell Receptor (TBA); Tolerance (TBA); Models of Autoim-
munity (I. Cohen, Israel); T Cells in Autoimmunity and
Allograft Rejection (A. Krensky, USA); Immunologic Toler-
ance (T. Strom, USA).
SYMPOSIA
1. MHC (Chair: P. Parham, USA)
Ontogeny of MHC Genes (P. Parham, USA); MHC
Class II Structure and Function (R. Germain, USA);
Processing of Class I Restricted Peptides (TBA); Proc-
essing of Class II Restricted Peptides (TBA).
2. T Cell Receptors and Repertoire Selection (Chair: TBA)
T Cell Receptor Structure and Assembly (TBA); Rep-
ertoire Selection (P. Kisielow, Switz.); TCR and CD3
(C. Terhorst, USA); Peptides in Thymic Selection (M.
Bevan, USA).
3. Central and Peripheral Mechanisms of Tolerance (Chair:
H.R. MacDonald, Switz,)
Positive and Negative Selection (D. Loh, USA); Clonal
Anergy (H.R. MacDonald, Switz.); The Gamma-Delta
Repertoire (M. Julius, Can.); Mechanisms of Allograft
Tolerance (B. Charpentier, France).
4. Cellular and Molecular Basis of Autoimmunity (Chair: A
Coutinho, France)
Antibody Structure (R. Poljack, France); B Cell Rep-
ertoire (A. Coutinho, France); Identification of Au-
toimmune Epitopes (TBA); T Cell Receptor Genes in
Autoimmunity (TBA).
5. Renal Autoimmunity (Chair: Ph. Druet, France)
Drug-Induced Autoimmunity (Ph. Druet, France); Al-
logenic Disease and Autoimmunity (M. Goldman,
Belg.); MHC, Class II and Autoimmunity (J. Weening,
Neth.); Renal Antigens in Glomerulonephritis (P. Ver-
roust, France).
6. New Specific Approaches to the Treatment of Auto- and
Alloimmunity (Chair: T. Strom, USA)
The Pharmacology of T Cell Activation (M.
Suthanthiran, USA); Anti-Idiotypic Antibodies (Y.
Schoenfied, Israel); T Cell Vaccination (F. Mor, Isra-
el); Monoclonal Antibodies (J.P. Soullilou, France).
7. New Perspectives in Transplantation (Chair: T. Strom,
USA)
Chimeric Toxins (T. Strom, USA); Xenograft Trans-
plantation (H. Auchincloss, USA); The Hypersensi-
tized Patient (F.H. Claas, Neth.); Blood Transfusions,
Cytotoxic Lymphocytes and Transplant Tolerance
(L.P. de Waal, Neth.).
8. Complications of Long-Term Immunosuppression
(Chair: J.H. Helderman, USA)
EBV and Post-Transplant Lymphoma (TBA); Hyperten-
sion, Lipids and Atherosclerosis Post-Transplantation
(J.H. Helderman, USA); HBV/HCV and the Post-
Transplant Patient (TBA).
International Society of Nephrology 513
THEME 4. HYPERTENSION
Organizer: P. Corvol, France
STA TE-OF-THE-ART LECTURES
Angiotensin Generation and Metabolism (M. Schalekamp,
Neth.); Genetics of Human Hypertension (R. Williams,
USA); Ecto-Enzymes and Blood Pressure Regulation (P.
Corvol, France); Intracellular Signalling Mechanisms in Hy-
pertension (P. Hamet, Can.); Ambulatory Monitoring of
Blood Pressure (G. Mancia, Italy).
SYMPOSIA
1. Renovascular Hypertension, 1993 (Chair: C. Wilcox,
USA)
Non-Invasive Diagnosis (A.B. Dardenne, Beig.); ACE
Inhibitors for Diagnosis of Renovascular Hypertension
(C. Wilcox, USA); Mini-Workshop on Treatment—
Surgeon (A. Novick, USA);—Angioplasty for Reno-
vascular Hypertension and Preservation of Renal
Function (T. Sos, USA);—Medical (T. Morgan,
Aust.).
2. Special Forms of Hypertension (Chair: A. Mimran,
France)
Hypertension in Transplantation (J. Curtis, USA);
Hypertension in Pregnancy (C. Redman, UK); Hyper-
tension in Child and Adolescent (B. Falkner, USA);
Ethnic Variations in Hypertension (H. Pratt, USA).
3. Molecular Genetics of Hypertension (Chair: D. Ganten,
Ger.)
Transgenic Approaches to the Study of Renin Gene
Expression (K. Gross, USA); Hypertension in Trans-
genic Animals (D. Ganten, Ger.); Mapping of Rat
Genome (T. Kurtz, USA); Finding Genes Causing
Hypertension (R. Lifton, USA).
4. Molecular Mechanisms in Hypertension (Chair: P. Cor-
vol, France)
Renin Processing (K. Murakami, Japan); The Regu-
lated Expression of the Renin Angiotensin System (K.
Bernstein, USA); Angiotensin Receptor Gene Expres-
sion and Regulation (T. Inagami, USA); Molecular
Structure, Function and Signalling of Alpha Receptors
(R. Graham, USA).
5. Peptide and Enzyme Inhibitors (Chair: 0. Carretero,
USA)
Vasoactive Peptides and Metalloendopeptidase Inhib-
itors in Hypertension (0. Carretero, USA); Dual Inhi-
bition of Neutral Endopeptidases and Angiotensin I
Converting Enzymes: Rational Design of Inhibitors
and Potential Interest as New Anti-Hypertensives (B.
Roques, France); All Receptor Antagonists (P. Tim-
mermans, USA); New Developments in ACE Struc-
ture, Regulation and Inhibition (F. Alhenc-Gelas,
France).
6. EDRF and Nitric-Oxide (Chair: L. Ignarro, USA)
L-Arginine-Nitric Oxide and Endothelin in Cardiovas-
cular Homeostasis and Experimental Hypertension (T.
Luscher, Switz.); NO and Transcellular Communica-
tion (L. Ignarro, USA); L-Arginine NO-Pathway and
the Glomerulus (L. Raij, USA).
7. Endothelin (Chair: F. Buhier, Switz.)
Molecular Basis of Synthesis and Action of Endothe-
lins (M. Yanagisawa, USA); Regulation of Endothelin
Gene Expression (C. Zoja, Italy); Endothelins as Reg-
ulators of Vascular Tone (F. Buhler, Switz., A.W.A.
Hahn, T.J. Resin, W. Kiowski, T.F. Luscher); The
Pathophysiology of Endothelin in Cardio-Renal Dis-
ease (J. Burnett, USA).
8. Prevention of Atherosclerosis by Antihypertensive
Treatment: Facts or Fancy? (Chair: N. Kaplan, USA)
Dietary Interventions (N. Kaplan, USA); Calcium
Channel Blockers (M. Safar, France); ACE Inhibitors
(H. Brunner, Switz.); Alpha Blockers (R. Graham,
USA).
THEME 5. ACUTE RENAL FAILURE
Organizer: K. Solez, Canada
STATE-OF-THE-ART LECTURES
Metabolic Basis of Cellular Injury (L. Mandel, USA); Role of
Calcium in Cell Injury (E. Carafoli, Switz.); Renal Biopsy in
Acute Renal Failure (K. Solez, Can.).
SYMPOSIA
1. Cellular Mechanisms of Injury I (Chair: S. Gullans, USA)
Plasma Membrane and Mitochondrial Injury (S. Gui-
lans, USA); Renal Proteases (P. Wilson, USA); Oxy-
gen-Free Radicals (S.V. Shah, USA); Alterations of
Membrane Fluidity (C. Le Grimellec, France).
2. Cellular Mechanisms of Injury II (Chair: B. Molitoris,
USA)
Disruption of Epithelial Polarity in Cellular Injury (B.
Molitoris, USA); Cytoskeletal Reorganization and De-
tachment in Injured Cells (L. Racusen, Can.); Ultra-
structural Alterations in Renal Cell Injury (M. Venka-
tachalam, USA); Intracellular Calcium in Acute Renal
Failure (H. Endou, Japan).
3. Cellular Mechanisms of Repair (Chair: W.D. Humes,
USA)
EGF in Repair of Renal Injury (H.D. Humes, USA);
Nucleotides and Nucleotidase Inhibition (N. Siegel,
USA); Glycine and Other Small Solules in Cell Repair
(J. Weinberg, USA); Multidrug Resistance Genes and
Cytotoxicity (K. Skorecki, Can.).
4. Mediators and Modifiers of Acute Renal Failure (Chair:
J. Conger, USA)
Arachidonic Acid Products (A. Morrison); EDRF and
ANP (J. Conger, USA); Endothelins (V. Kon, USA);
TNF and PAF in ARF (J.M. Lopez-Novoa, Spain).
5. Clinical Spectrum of Acute Renal Failure (Chair: F.
Epstein, USA)
ARF in Pregnancy (M. Beaufils, France); Hepatorenal
Syndrome (J. Green, USA); ARF in Rhabdomyolysis
(0. Better, Israel); Post-Transplant ARF (U. Frei,
Ger.).
6. Clinical Strategies for Enhancing Recovery of ARF
(Chair: N. Lemeire, Belg.)
Ca Channel Blockers (M. Epstein, USA); Diuretics
and ANP (W. Leiberthal, USA); Pathophysiologic
Implications (W. Finn, USA); Dialytic and Nutritional
Strategies (H.E. Eliahou, Israel).
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THEME 6. DIALYSIS
Co-Organizers: K. Koch, Ger,nany
R. Hakim, USA
STATE-OF-THE-ART LECTURES
Adequacy of Dialysis: An Important Determinant of Morbid-
ity and Mortality (R. Lindsay, Can.); Erythropoietin: The
Promise and the Facts (J. Eschbach, USA); Biocompatibility
of Dialysis Membranes (E. Ritz, Ger.); Dialysis of the Dia-
betic Patient: Problems and Solutions (A. Collins, USA);
Immunological Considerations of the Dialysis Patient (L.
Chatenoud, France).
SYMPOSIA
1. Advances in Hemodialytic Techniques (Chair: N.W.
Levin, USA)
Advances in Dialysate Composition (K.M.L. Leunis-
sen, Neth.); Advances in Membrane Technology (H.
Graf, Aus.); On-Line Assessment of Dialysis (N.W.
Levin, USA); Continuous Hemofiltration and Hemodi-
alysis (H.G. Sieberth, Ger.).
2. Advances in Peritoneal Dialysis Technology (Chair: J.
Diaz-Buxo, USA)
CAPD Technology (J. Diaz-Buxo, USA); Advances in
Dialysate Composition (B. Linhoim, Sweden); Ad-
vances in Connectology and Dialysate Delivery Tech-
niques (M. Nakamota, Japan); Advances in Assess-
ment of Adequacy in CAPD (F. Gotch, USA).
3. Erythropoietin I (Chair: F. Valderrabano, Spain)
Cardiovascular Effects of EPO (Valderrabano, Spain);
Metabolic Effects of EPO (C-S. Lee, Korea); Rehabil-
itation Alter Starting EPO (A. Nissenson, USA); Im-
munological Effects of EPO (U. Gafter, Israel).
4. Erythropoietin II (Chair: V. Lim, USA)
Effect of EPO on Adequacy of Dialysis (V. Lim, USA);
Routes, Frequency of Administration and Effect of
Dialysis Membranes (TBA); Effect of EPO on Progres-
sion of Renal Disease (TB A); Effect of EPO on Platelet
and WBC Function (R. Castillo, Spain).
5. Clinical Relevance of Biocompatibility (Chair: C. Van
Ypersele, Belg.)
Amyloidosis: Is It Related To Biocompatibility? (C.
Van Ypersele, Beig.); Infections in Dialysis Patients
(R. Van Holder, Beig.); Adequacy and Malnutrition in
Dialysis Patients: Is It Related To Biocompatibility? (J.
Bergstrom, Sweden); Cytokine Hypothesis (L. Hend-
erson, USA).
6. Peritoneal Dialysis (Chair: N. Thompson, Aust.)
Host Defense in CAPD (PD Cytology and Toxicology),
(F.B. Pederson, Den.); Peritonitis: Advances in Diag-
nosis and Treatment (R. Gagnon, Can.); Determinants
of Success of Long-Term CAPD (N. Thompson,
Aust.); Loss of Ultrafiltration in CAPD (R. McTier,
UK).
7. Improvements in Delivery of Dialysis (Chair: V. Bono-
mini, Italy)
Chronic Access Patency: Problems and Solutions (S.
Schwab, USA); Advances in Renal Replacement Ther-
apy: High Flux/High Efficiency (J. Botella, Spain);
Endotoxins and Pyrogenic Reactions in High Flux
Dialyzers (G. Lonneman, Ger.); Determination of Re-
circulation (T. Depner, USA).
8. Advances in Diagnosis and Treatment of Bone Diseases
and Metastatic Calcification (Chair: F. Liach, USA)
Role of Vitamin D (Oral and IV) and Dialysate Calcium
(F. Liach, USA); Phosphate Control, PTH and Calci-
tonin in Dialysis Patients (G. Coen, Italy); Role of
Aluminum and Iron in Bone Disease (TBA); Amyloid
Bone Disease (T. Druëke, France).
9. Dialysis, Pheresis and Immunoabsorption in Special Pop-
ulations (Chair: C.M. Lockwood, UK)
Dialysis in Patients with Chronic Infection (T.K.S.
Rao, USA); Plasmapheresis in the Treatment of Sys-
temic Diseases (C.M. Lockwood, UK); Immunoab-
sorption and Other Techniques for Removal of Choles-
terol (C. Olbricht, Ger.).
THEME 7. DIABETIC GLOMERULOPATHY
Co-Organizers: G. C. Vigerti, UK
H.H. Parving, Denmark
STATE-OF-THE-ART LECTURES
The Pathogenesis of Diabetes Mellitus (H. Keen, UK);
Animal and Human Models of Renal Injury in Diabetes (M.
Mauer, USA).
SYMPOSIA
1. Glomerular Response to Hyperglycaemia and Diabetes
(Chair: G.C. Viberti, UK)
The Role of Glycosylation in Diabetic Glomerulopathy
(H. Vlassara, USA); Role of Cell Membrane Transport
Systems in Human Diabetic Nephrology (R. Trevisan,
Italy); The Giomerular Mesangium in Diabetes Melli-
tus (J. Kreisberg, USA); Modulators of Renal Function
in Human Diabetes (J. Sandahi Christiansen, Den.).
2. Similarities and Differences Between IDDM and NIDDM
(Chair: T. Deckert, Den.)
Epidemiological Aspects of Renal and Cardiovascular
Disease in IDDM vs. NIDDM (A. Krolewski, USA);
Glomerular Function in IDDM vs. NIDDM (B. Myers,
USA); Microalbuminuria in IDDM and NIDDM (C.E.
Mogensen, Den.); Insulin Resistance and Its Vascular
Complications in Diabetes (E. Ferrannini, Italy).
3. Prevention and Treatment of Diabetic Nephropathy
(Chair: H.H. Parving, Den.)
Prevention of Diabetic Nephropathy: Studies in Micro-
albuminuric Patients (H.H. Parving, Den.); Low Pro-
tein Diet in the Prevention and Treatment of Diabetic
Nephropathy (G.C. Viberti, UK); Antihypertensive
Treatment in Diabetic Nephropathy (S. Bjorck, Swe-
den); Blood Glucose Control and Diabetic Nephrop-
athy (J. Barbosa, USA).
4. Treatment of ESRD in Diabetes (Chair: E.A. Friedman,
USA)
Participants: R. Nakache, Israel; R. Bilous, UK; C.
Jacobs, France; H. Brynger, Sweden; R. Gokal, UK;
J. Jervel, Nor.
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ADDITIONAL TOPICS
STA TE-OF-THE-ART LECTURES
The Kidney and Calcium Regulating System (K. Kurokawa,
Jap.); Biology Physiology and Pathophysiology of PTH-RP
(J. Martin, Aust.); Immunotactoid Nephropathy (S. Korbet,
USA); Biology of Aging (S. Gambert, USA); FK506 (TBA);
Mechanisms of Tubulointerstitial Fibrosis (E. Neilson,
USA).
SYMPOSIA
I. Renal Calcium Transport (Chair: R. Kumar, USA)
Ca-ATPase (J. Lytton, USA); Ca Channels (TBA);
Mechanism of Action of PTH on Ca2 Transport in the
Distal Nephron Segment (K. Yoshitomi, Japan); Role
of Vitamin D in Tubular Calcium Transport (R. Kumar,
USA).
2. Renal Phosphate Transport (Chair: M. Levi, USA)
Purification, Characterization and Cytolocalization of
the Sodium Phosphate Co-Transporter (H. Debiec,
France); Interaction of PTH and Vitamin D Derivaties
in the Regulation of Renal Phosphate Transport (M.M.
Popovtzer, Israel); The Role of Growth Factors in
Renal Phosphate Transport (M.R. Hammerman,
USA); The Role of Perturbations in Membrane Lipid
Composition and of Fluidity in the Regulation of Phos-
phate Transport (M. Levi, USA).
3. Receptors and Molecular Action of Calcium Regulating
Hormones (Chair: E. Ogata, Japan)
Molecular Action of Vitamin D Receptors (J.W. Pike,
USA); Characterization of Clone PTH/PTH-Related
Peptide Receptors (G. Segre, USA); Calcitonin Recep-
tor (S. Goldring, USA); G Proteins (E. Ogata, Japan).
4. Clinical Application of Vitamin D and Its Analogues
(Chair: T. Suda, Japan)
The Role of Vitamin D in Bone (T. Suda, Japan);
Clinical Use of 1 ,25(OH)2D3 in Uremic Bone Disease
and Its Analogues (E. Slatopolsky, USA); Clinical Use
of 24,25(OH)2D3 in Uremic Bone Disease (D. Rubin-
ger, Israel); New Vitamin D Analogues (Y. Nishii,
Japan).
5. Polycystic Kidney Diseases (Chair: S. Reeders, USA)
Molecular Genetics (M. Brueuing, Neth.); Pathophys-
iology of Cyst Formation and Progression (E. Avner,
USA); Progression of Cystic Renal Disease (P.S. Par-
frey, Can.); Recessive PKD (L. Guay-Woodford,
USA).
6. Alport Syndrome (Chair: K. Tryggvason, Fin.)
AlphaS (IV) in Normal and in Alport Basement Mem-
brane (K. Tryggvason, Fin.); Molecular Defects in
Families with Alport Syndrome (B. Knebelmann,
France); Correlation Between Clinical Presentation,
Pathological Changes and DNA Lesions (C. Kashtan,
USA); Thin Membrane Nephropathy: A Critical Re-
view (R. Waldherr, Ger.).
7. Genetic Counseling in Inherited Kidney Diseases (Chair:
J.P. Grunfeld, France)
Participants: J.J. Grantham, USA; M. Levy, France;
F. Flinter, UK; 0. Germino, USA.
8. Von Hippel-Lindau Syndrome and Renal Tumors (Chair:
B.R. Seizinger, USA)
Molecular Genetics of Von Hippel-Lindau Syndrome
(B.R. Seizinger, USA); Molecular Genetics of Renal
Cell Carcinoma (A. Feinberg, USA); Clinical Aspects
of Von Hippel-Lindau Disease (H.P.H. Neumann,
Ger.).
9. Immunotactoid Nephropathy (Chair: M. Pras, Israel)
Chemical Classes of Amyloidosis (B. Frangione,
USA); Precursors of SAA Amyloid Fibrils (M. Peppys,
UK); Correlation Between Clinical Symptoms and
Chemical Structure of Fibrils (M. Pras, Israel); Thera-
peutic Approach to Amyloidosis (D. Zemer, Israel).
10. Lipids and Renal Disease (Co-Chairs: J. Moorhead, UK;
W.F. Keane, USA)
Effect on Lipids on the Renal Interstitium and Tubule
Cells (J. Moorhead, UK); Effect on Lipids on Glomer-
ular Mesangial Cell Biology and Matrix Regulation
(W.F. Keane, USA); Effect of Lipids on Glomerular
Macrophage Recruitment and Function (J. Diamond,
USA); Nephrotic Syndrome and Hyperlipidemia:
Causes and Consequences (G. Kaysen, USA).
11. Hypertension in the Elderly (Chair: H. Gavras, USA)
Pathophysiology (H. Gavras, USA); Cholesterol Ab-
normalities in the Elderly (R. Hegele, Can.); Should
Hypertension Be Treated in the Elderly? (TBA); Treat-
ment Regimens for Hypertension in the Elderly (R.
Oglivie, Can.).
12. End-Stage Renal Disease in the Elderly (Chair: D. Ore-
opoulos, Can.)
Hemodialysis in the Elderly (E.A. Friedman, USA);
Peritoneal Dialysis in the Elderly (D. Oreopoulos,
Can.); Transplantation in the Elderly (H. Brynger,
Swe.); Decisions to Forego Treatment in the Elderly
(C. Kjellstrand, USA).
13. Natriuretic Substances (Chair: M.L. Zeidel, USA)
Atrial Natriuretic Peptides (M.L. Zeidel, USA);
Urodilatin and Renally Derived Natriuretic Peptides
(W.G. Forssman, Ger.); Regulation of Renal Na/K-
ATPase (A. Aperia, Sweden); Endogenous Ouabain-
Like Factors (M.P. Blaustein, USA).
14. Cyclosporine in Non-Transplant Renal Diseases
Cyclosporine in Experimental Models of Proteinuria
Mechanisms of the Anti-Proteinuric Effect (H.M. Ber-
den, Neth.); CyA in Minimal Change and Focal Seg-
mental Sclerosis (P. Niaudet, France); CyA in Mem-
branous Nephropathy (D.C. Cattran, Can.); CyA in
SLE and Vasculitis (H. Favre, Switz.).
15. AIDS and the Kidney (Chair: J. Bourgoignie, USA)
Nephropathy in Simian Aids (C. Alpers, USA); Renal
Complications of HIV Infections (M. Humphreys,
USA); HIV-Associated Nephropathy and Epidemiol-
ogy, Clinical Manifestations and Treatment (J. Bour-
goignie, USA); Pathology and Pathogenesis of HIV-
Associated Nephropathy (R.P. Chander, USA);
Pathogenesis of HIV-Associated Nephropathy (H.
Kimmel, USA).
16. Tubulointerstitial Injury (Chair: V. Rubin-Kelley, USA)
Molecular Mechanisms of Tubulointerstitial Growth
(G. Wolf, Ger.); Mononuclear Cell Infiltration and Its
Correlation With Interstitial Injury and Renal Failure
(R. Atkins, Aust.); Mechanisms of Immune-Epithelial
Cell Adhesion (V. Rubin-Kelley, USA); Molecular
Regulation of Nephritogenic T Lymphocytes (C.
Kelly, USA).
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PLUS
1. Clinical Case Discussions daily.
2. A special Nephrology Forum for subsequent publication
in Kidney International.
3. Quiz of the Day.
4. Clinical "Debates" or Panel Discussions daily on such
topics as Nephrolithiasis (A. Fournier, France); Recur-
rent Urinary Tract Infection (J. Michel, Israel); New
Modalities for Treatment of Glomerulonephritis (C. Pon-
ticelli, Italy); New Imaging Techniques (A. Dardenne,
Belg.); Diagnostic Approach in Asymptomatic Hema-
tuna (P. Kincaid-Smith, Aust.); Drug-Induced Nephrop-
athy (W.M. Bennett, USA).
ISN Sponsorship of Meetings
The International Society of Nephrology (ISN) encourages
the organizers of scientific symposia, workshops, and confer-
ences held independently of the International Congress of
Nephrology to apply to hold these meetings under the auspices
of ISN.
In general, such an arrangement does not include an offer of
financial support on the part of ISN. In special cases, however,
the Society may be able to offer seed money.
Organizers who wish to apply to hold their meetings under
the auspices of the Society should include the following infor-
mation in their applications:
1. Topic and purpose of meeting.
2. Location and date of meeting.
3. Names of members of scientific organizing committee.
4. Names of co-sponsors and sources of financial support.
5. Names and topics of invited speakers.
6. Statement regarding whether or not free communications
will be sought.
Applications will not be accepted from organizers of regu-
larly, or routinely, scheduled regional, national, or international
meetings.
Applicants should be submitted to Dr. Claude Arnie!, Secre-
tary General, ISN, Department de Physiologie, 16, rue Henri-
Huchard, 75018 Paris, France.
Publications and announcements of meetings held under
ISN's auspices should include the statement of acknowledge-
ment: ". . .was held under the auspices of the International
Society of Nephrology."
Membership
Any member of a national society of nephrology is eligible for
proposal to membership in the International Society of Nephro-
logy and receipt of the Society's official Journal, Kidney Inter-
national. A subscription to Kidney International (including all
Supplements) for calendar year 1991 is included in the annual
199! dues of US $100.00. Potential members can secure appli-
cation forms for membership by writing directly to Dr. C. Craig
Tisher, Treasurer, International Society of Nephrology, P.O.
Box J-23l, J. Hillis Miller Health Center, 1600 SW Archer Rd.,
University of Florida, Gainesville, Florida 32610, USA. The
completed application form must be signed by two sponsors
who are current Fellow members of the ISN and then returned
to Dr. Tisher along with a check or money order for the first
year's dues of $100.00. (Checks should be made payable to the
International Society of Nephrology. Checks from outside the
USA can be paid through any United States bank.)
Guidelines for sponsorship of symposia, postgraduate
courses, or workshops by the International Society of
Nephrology
The International Society of Nephrology (ISN) encourages
the organizers of scientific symposia, postgraduate courses, or
workshops to apply to the Society for sponsorship. ISN spon-
sorship will provide: (1) use of the Society's name as a sponsor
or co-sponsor; (2) announcement of the meeting in Kidney
International, contingent upon the receipt of written informa-
tion in the Editorial office at least 6 months in advance of the
meeting; (3) the possibility of partial financial support. Appli-
cations must include the following information: (1) the topic,
purpose, location and date(s) of the meeting; (2) the names and
titles of the members of the scientific organizing committee; (3)
a list of all co-sponsoring institutions, if any, and sources of
financial support; (4) the total revenue and expense budget for
the proposed meeting, by major category; (5) the names and
institutions of origin of all invited speakers, and their topics; (6)
a statement as to whether manuscripts will be solicited from
invited speakers, or free communications sought from others;
(7) an expression of willingness to include the following ac-
knowledgment on all publications: ". . . was held under the
auspices of the International Society of Nephrology."
These guidelines do not apply to satellite symposia to be held
in close proximity to a triennial Congress. Furthermore, the
ISN will not sponsor or co-sponsor any regularly scheduled or
routine international, national, or regional meeting, nor will it
co-sponsor postgraduate courses with other international soci-
eties or groups.
Applications for sponsorship must be submitted directly to
Dr. Roscoe R. Robinson, President, International Society of
Nephrology, D-3300 Medical Center North, Vanderbilt Univer-
sity School of Medicine, 21st Avenue South at Garland, Nash-
ville, Tennessee 37232, USA.
!SN Archives
Dr. Carl Gottschalk has accepted the responsibility to estab-
lish an Archive of the International Society of Nephrology. The
Archive will consist of photographs, announcements, activities,
and names of Council Members and Officers of the Society.
Relevant information, documents, or photographs that are
pertinent to the development and evolution of the ISN will be
assembled in the Archive.
Members of the ISN or other readers of Kidney International
having such material are requested to forward it to Dr. Gottscha!k
at the following address: Carl W. Gottschalk, M.D., Depart-
ment of Medicine 226-H, University of North Carolina, Chapel
Hill, North Carolina 27514 USA.
MEETINGS
The Vii International Symposium on Urolithiasis and Re-
lated Clinical Research will be held in Cairns, Australia on
August 24—27, 1992. Topics will include: epidemiology of
stones; physiology, metabolism and biochemistry; medical and
surgical treatment, including lithotripsy; and physicochemical
aspects of stone formation. For futher information, contact Dr.
